Table of Contents
II. Why Isn't Jardiance Generic Available in the U.S.?
III. Impact on Patients Taking Jardiance
IV. Canadian Pharmacies: A Path for Accessing Jardiance Generic
In the world of modern healthcare, managing chronic conditions like Type 2 diabetes is as much about cost and accessibility as it is about efficacy. Jardiance has made a huge impact on Type 2 diabetes management over the past decade, but the lack of Jardiance generic options in U.S. markets has also made it cost-prohibitive for many patients.
In this article, we’ll explore exactly why Jardiance generic is still not available in the U.S., plus how U.S. patients can access it safely and affordably through a Canadian pharmacy.
Quick Takeaways:
- Jardiance is an oral SGLT-2 inhibitor that treats Type 2 diabetes and has also been proven to reduce cardiovascular risks.
- Jardiance generic won’t be available in the U.S. until at least 2025 (and it will likely be longer) due to patent protection and market exclusivity policies.
- U.S. patients can order Jardiance generic from a Canadian online pharmacy if they have a valid prescription from a U.S.-licensed healthcare provider.
Understanding Jardiance
Jardiance (generic name empagliflozin) has become a cornerstone in the treatment of Type 2 diabetes. It operates by inhibiting the SGLT2 protein in the kidneys, which stops the kidneys from absorbing too much sugar back into the blood. Instead, this sugar is passed out of the body in urine, which helps lower overall blood sugar levels.
Approved by the FDA in 2014, Jardiance quickly established itself as a vital medication for adults with Type 2 diabetes, particularly due to its multifaceted benefits. Beyond its primary role in glycemic control, Jardiance has been noted for its cardiovascular advantages.
Clinical studies have demonstrated its efficacy in reducing the risk of cardiovascular death in diabetes patients with known heart disease, marking a significant breakthrough in diabetes care.
Jardiance’s impact also extends to improving diabetes management and quality of life for patients. Its once-daily oral dosing regimen offers convenience and ease of use, which is crucial for long-term treatment adherence. The drug's development and subsequent approval symbolized a leap forward in diabetes treatment that offered patients an effective tool for managing their condition, while also addressing broader cardiovascular risks.
Why Isn't Jardiance Generic Available in the U.S.?
It’s important to note that Jardiance generic does exist—it’s just not available to patients in the United States. The absence of a generic version of Jardiance in the U.S. market can be attributed to a combination of patent laws, market exclusivity rights, and structured timelines for bringing generic drugs to market.
In the U.S., when a new drug like Jardiance is developed, it is protected by patents. These patents prevent other companies from making and selling generic versions of the same drug for a certain period, typically 20 years from the date of filing.
Beyond patents, the FDA also grants new drugs a period of market exclusivity, a time period during which no generic equivalent can be approved, often lasting several years. This period of exclusivity is crucial for pharmaceutical companies to recover the substantial costs associated with researching and developing a new drug, which often involves a high level of investment over many years.
During patent protection and market exclusivity periods, the original manufacturer of a drug may set its price without generic competition, which can lead to higher costs for consumers.
Jardiance's current patent protection extends until 2025, without taking into account potential patent extensions (which are often granted). [2] This means that the soonest Jardiance generic will be available in the U.S. is 2025, but it’s likely to be longer.
Impact on Patients Taking Jardiance
The lack of a generic alternative for Jardiance in the U.S. market significantly impacts patients who rely on this medication for managing Type 2 diabetes. The consequences of this situation extend beyond just the clinical benefits of the drug to the financial realities of those requiring ongoing treatment.
1. Financial Burden
Without a generic version, patients are often subject to the higher costs associated with brand-name medications. For individuals without comprehensive insurance coverage or those in high-deductible health plans, affording Jardiance can be a substantial financial strain. The average retail cost of Jardiance on U.S. retail markets is higher than $700, and even with coupons and discounts stays above $550. [3]
The cost barrier may lead to challenges in medication adherence. Some patients might skip doses, reduce their intake, or even stop using the medication altogether due to cost, which can negatively impact their diabetes management.
2. Access and Availability
Insurance plans may have limitations or restrictions on coverage for brand-name drugs like Jardiance, leaving patients with high out-of-pocket expenses. Patients might find themselves in a position in which they need to explore alternative treatments or medications, which may not be as effective.
3. Psychological Impact
The financial burden and concerns about access to Jardiance can contribute to increased stress and anxiety for patients, which is an often overlooked aspect of healthcare affordability issues. Psychological stress can also exacerbate physical symptoms, leading to health difficulties and worse outcomes.
4. Health Outcomes
Inconsistent use of Jardiance due to affordability issues can lead to poor glycemic control, increasing the risk of diabetes-related complications over time.
The absence of Jardiance generic in the U.S. underscores a broader issue in healthcare affordability and access, directly affecting patients’ ability to manage their chronic conditions effectively. For those who are dependent on Jardiance, navigating these challenges requires not only financial resources but also support from healthcare providers to find the most viable and effective solutions.
Canadian Pharmacies: A Path for Accessing Jardiance Generic
While the U.S. market awaits the arrival of a generic version of Jardiance, Canadian pharmacies emerge as a potential pathway for accessing more affordable options. In Canada, the pharmaceutical landscape, governed by different patent laws and pricing regulations, allows for earlier availability of generics. This offers an opportunity for U.S. residents seeking cost-effective alternatives for their diabetes medication.
Because the FDA has approved Jardiance generic for safety, U.S. patients can legally import it from Canada to the United States. This can be done conveniently through a Canadian mail-order pharmacy as long as certain requirements are met, including a prescription from a U.S.-licensed healthcare provider.
Canadian online pharmacies are highly regulated by the Canadian International Pharmacy Association (CIPA), and consumers can trust that CIPA-certified pharmacies provide safe, authentic medications.
My Drug Center is one such Canadian pharmacy, helping thousands of U.S. patients save on Jardiance and other prescription drugs every day.
Learn more here about ordering your next prescription from My Drug Center.
The information in the article is not meant to be used for treatment or diagnosis. It is designed for general awareness and for information purposes only. Always consult a medical professional for your specific healthcare needs.
Do Jardiance and Metformin Work Better Together?